Correlation Between Sarofim Equity and Jpmorgan Growth

Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Jpmorgan Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Jpmorgan Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarofim Equity and Jpmorgan Growth Advantage, you can compare the effects of market volatilities on Sarofim Equity and Jpmorgan Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Jpmorgan Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Jpmorgan Growth.

Diversification Opportunities for Sarofim Equity and Jpmorgan Growth

0.77

Correlation Coefficient

Sarofim Equity  Jpmorgan Growth

Poor diversification

The 3 months correlation between Sarofim and Jpmorgan is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Jpmorgan Growth Advantage in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jpmorgan Growth Advantage and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Jpmorgan Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jpmorgan Growth Advantage has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Jpmorgan Growth go up and down completely randomly.

Pair Corralation between Sarofim Equity and Jpmorgan Growth

Assuming the 90 days horizon Sarofim Equity is expected to generate 0.63 times more return on investment than Jpmorgan Growth. However, Sarofim Equity is 1.59 times less risky than Jpmorgan Growth. It trades about -0.07 of its potential returns per unit of risk. Jpmorgan Growth Advantage is currently generating about -0.11 per unit of risk. If you would invest  1,415  in Sarofim Equity on December 30, 2024 and sell it today you would lose (59.00) from holding Sarofim Equity or give up 4.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sarofim Equity  vs.  Jpmorgan Growth Advantage

Sarofim Equity

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Jpmorgan Growth Advantage

Risk-Adjusted Performance

Very Weak

Over the last 90 days Jpmorgan Growth Advantage has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Pair Trading with Sarofim Equity and Jpmorgan Growth

The main advantage of trading using opposite Sarofim Equity and Jpmorgan Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Jpmorgan Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jpmorgan Growth will offset losses from the drop in Jpmorgan Growth's long position.

The idea behind Sarofim Equity and Jpmorgan Growth Advantage pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.